Varivax III is currently available from Merck Frosst to help protect children, age 12 months andolder, against chickenpox

In clinical trials, antibodies against the varicella virus were observed at 4 to 6 weeks following vaccination with VARIVAX ŽIII in 97% of children 12 months to 12 years of age.